SCYNEXIS Europe is Now Selcia Following Spin Off From SCYNEXIS, Inc.
06-Jan-2006 -
SCYNEXIS, Inc., a medicinal chemistry-focused drug discovery and development company, has sold its wholly-owned subsidiary in the United Kingdom, SCYNEXIS Europe Limited, to its U.K. management. The new company will operate under the name Selcia Limited.
Dr. Hans Fliri, the Managing Director of ...
bases
chemistry
medicinal chemistry
+4